Insulet Corp (MIL:1PODD)
€ 140.2 (0%) Market Cap: 10.00 Bil Enterprise Value: 10.41 Bil PE Ratio: 38.27 PB Ratio: 8.75 GF Score: 62/100

Q4 2024 Insulet Corp Earnings Call Transcript

Feb 20, 2025 / 09:30 PM GMT

Key Points

Positve
  • Insulet Corp (PODD) achieved its ninth consecutive year of 20% or more constant currency revenue growth, surpassing $2 billion in revenue for the first time.
  • The company reported strong demand for its Omnipod 5 platform, with over 500,000 global customers and 355,000 active Omnipod 5 users.
  • Insulet Corp (PODD) expanded its international presence, launching Omnipod 5 in multiple European countries, including Italy, Denmark, Finland, Norway, and Sweden.
  • The company successfully integrated Omnipod 5 with Abbott's FreeStyle Libre 2 and Dexcom's G7 sensors, enhancing its product offerings.
  • Insulet Corp (PODD) reported a gross margin of 72.1% in Q4, driven by U.S. volume, Omnipod 5 pricing, and improved manufacturing efficiencies.
Negative
  • The company faces pricing headwinds as it transitions to the pharmacy channel, impacting revenue growth comparisons.
  • International pricing is lower than U.S. pricing, which presents a headwind to gross margin as international sales grow.
  • Insulet Corp (PODD) anticipates a decline in drug delivery revenue by 45% to 55% in 2025.
  • The company is investing heavily in R&D and sales and marketing, which may impact short-term profitability.
  • There is a risk of increased competition in the type 2 diabetes market as other companies seek FDA approval for similar products.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PODD.OQ - Insulet Corp
Q4 2024 Insulet Corp Earnings Call
Feb 20, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Me, too.

I mean, good afternoon, ladies and gentlemen, and welcome to the Alpha Corporation Fourth Quarter and Full Year 2024 earnings call.

At this time, all participants are in a listen only mode.

Later we will conduct a question and answer session and instructions will follow at that time.

If anyone should require assistance during the conference, please press star then zero on your touch tone telephone.

As a reminder, this conference call is being recorded.

I would now like to turn the conference over to your host, June Lazaros , Senior Director, Investor Relations.

Please go ahead.

Good afternoon, and thank you for joining us.

For instance, let's Fourth
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot